EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The increased co-expression of SLC7A11 and PD-L1 was associated with poor prognosis in extranodal natural killer T-cell lymphoma patients

Cuiying He, Yingzhen Yao, Xiaolin Wu, Meng Yue, Lingling Zhang, Xiaojie Fan, Yuan Li, Chen Zhao, Haisheng Liu

Cancer Immunology, Immunotherapy · 2026

DOI: 10.1007/s00262-026-04484-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Cuiying He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, People's Republic of…. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Amino Acid Transport System y+, B7-H1 Antigen, Biomarkers, Tumor. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hebei Natural Science Foundation, Medical Science Research Project of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Extranodal NK-T-CellAmino Acid Transport System y+B7-H1 AntigenBiomarkers, TumorHumansFemalePrognosisMaleMiddle AgedAdultAged

Stichwörter der Autor:innen

Extranodal natural killer/T cell lymphomaPD-L1SLC7A11

Substanzen

Amino Acid Transport System y+SLC7A11 protein, humanB7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, People's Republic of China. hecuiying@hebmu.edu.cn.
  • Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, People's Republic of China.
  • Department of Pharmacology, The Fourth Hospital of Hebei University of Chinese Medicine, Shijiazhuang, People's Republic of China.
  • Department of Hematology, The Fourth Hospital of Hebei Medical University, NO.169, TianShan Street, Shijiazhuang, 050035, Hebei, People's Republic of China. liuhs78299@hebmu.edu.cn.

Förderung

  • Hebei Natural Science Foundation
  • Medical Science Research Project of Hebei

Zitieren

APA

He, C., Yao, Y., Wu, X., Yue, M., Zhang, L., Fan, X., Li, Y., Zhao, C., & Liu, H. (2026). The increased co-expression of SLC7A11 and PD-L1 was associated with poor prognosis in extranodal natural killer T-cell lymphoma patients. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04484-y

Vancouver

He C, Yao Y, Wu X, Yue M, Zhang L, Fan X, et al. The increased co-expression of SLC7A11 and PD-L1 was associated with poor prognosis in extranodal natural killer T-cell lymphoma patients. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04484-y

BibTeX
@article{He2026,
  author = {He, Cuiying and Yao, Yingzhen and Wu, Xiaolin and Yue, Meng and Zhang, Lingling and Fan, Xiaojie and Li, Yuan and Zhao, Chen and Liu, Haisheng},
  title = {The increased co-expression of SLC7A11 and PD-L1 was associated with poor prognosis in extranodal natural killer T-cell lymphoma patients},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  doi = {10.1007/s00262-026-04484-y}
}
Kostenlos starten →